ECL
50
-2
ACN
54
2
COST
45
-2
BK
74
-5
TXT
65
-3
UNM
54
-5
HPE
66
-2
ALL
58
2
AKAM
37
-2
MAC
57
3
WFC
71
-3
PFE
39
-7
EQT
51
-3
STI
21
3
ADSK
61
-2
JBHT
35
-4
NTRS
64
-6
HPQ
52
-5
BAX
48
-2
CI
42
-3
ECL
50
-2
ACN
54
2
COST
45
-2
BK
74
-5
TXT
65
-3
UNM
54
-5
HPE
66
-2
ALL
58
2
AKAM
37
-2
MAC
57
3
WFC
71
-3
PFE
39
-7
EQT
51
-3
STI
21
3
ADSK
61
-2
JBHT
35
-4
NTRS
64
-6
HPQ
52
-5
BAX
48
-2
CI
42
-3
Financhill
Back

Avenue Therapeutics Stock Predictions

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
37

ATXI
Avenue Therapeutics

Last Price:
$0.24
Seasonality Move:
-10.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Avenue Therapeutics Stock Forecast

  • Is Avenue Therapeutics Stock Undervalued?
    The current Avenue Therapeutics [ATXI] share price is $0.26. The Score for ATXI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ATXI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Avenue Therapeutics Stock Go Up Next Year?

Data Unavailable

Avenue Therapeutics Stock Rating

Data Unavailable

Avenue Therapeutics Stock Price History

Is ATXI stock going to rise?

  • The current trend is relatively stagnant and ATXI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
avenuetx.com

52-Week Data

52-Week High:
3.99
52-Week Low:
0.17

Prediction Charts

Market Cap:
827.4K
Price in USD:
0.26
Volume:
3.2K
Beta:
-0.01

Technical Analysis

SMA50:
0.27
SMA100:
0.85
SMA200:
1.56
52-Wk Change:
-92.99%

Stock Predictions

  • Is Avenue Therapeutics stock public?
    Yes, Avenue Therapeutics is a publicly traded company.
  • What is the Avenue Therapeutics stock quote today?
    The Avenue Therapeutics stock price is 0.26 USD today.
  • How to buy Avenue Therapeutics stock online?
    You can buy Avenue Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-8 0.23 0.22 0.25 0.22
May-9 0.24 0.24 0.24 0.24
May-12 0.25 0.24 0.25 0.23
May-13 0.17 0.18 0.18 0.17
May-14 0.18 0.24 0.25 0.18
May-15 0.23 0.25 0.25 0.23
May-16 0.22 0.22 0.22 0.22
May-19 0.25 0.22 0.25 0.22
May-20 0.22 0.22 0.22 0.22
May-21 0.22 0.22 0.22 0.22
May-22 0.22 0.22 0.22 0.22
May-23 0.23 0.21 0.23 0.21
May-27 0.20 0.25 0.25 0.20
May-28 0.20 0.26 0.26 0.17

Avenue Therapeutics Earnings

Data Unavailable

Avenue Therapeutics Forecast Revenue Growth

Data Unavailable

* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.